Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Holdings of the Fund as of 11/18/2026
View Index Holdings

Total Number of Holdings (excluding cash): 50

Security Name Identifier CUSIP Classification Shares / Quantity Market Value Weighting Descending sort
Eli Lilly and Company LLY 532457108 Pharmaceuticals 64,456 $89,126,534.00 8.23%
AbbVie Inc. ABBV 00287Y109 Pharmaceuticals 290,758 $83,159,695.58 7.68%
Johnson & Johnson JNJ 478160104 Pharmaceuticals 280,440 $76,475,988.00 7.06%
Pfizer Inc. PFE 717081103 Pharmaceuticals 2,619,683 $73,508,304.98 6.79%
Merck & Co., Inc. MRK 58933Y105 Pharmaceuticals 504,578 $69,520,756.84 6.42%
Viatris Inc. VTRS 92556V106 Pharmaceuticals 2,257,908 $45,790,374.24 4.23%
Regeneron Pharmaceuticals, Inc. REGN 75886F107 Biotechnology 46,648 $44,107,083.44 4.07%
Biogen Inc. BIIB 09062X103 Biotechnology 172,068 $43,259,615.88 4.00%
Gilead Sciences, Inc. GILD 375558103 Pharmaceuticals 254,742 $43,046,303.16 3.98%
Zoetis Inc. ZTS 98978V103 Pharmaceuticals 483,506 $41,373,608.42 3.82%
Amgen Inc. AMGN 031162100 Pharmaceuticals 86,722 $38,495,028.58 3.56%
United Therapeutics Corporation UTHR 91307C102 Pharmaceuticals 64,838 $37,433,570.92 3.46%
Vertex Pharmaceuticals Incorporated VRTX 92532F100 Pharmaceuticals 68,461 $36,725,903.45 3.39%
Incyte Corporation INCY 45337C102 Biotechnology 299,154 $35,240,341.20 3.26%
Bristol-Myers Squibb Company BMY 110122108 Pharmaceuticals 557,975 $33,232,991.00 3.07%
Jazz Pharmaceuticals Plc JAZZ G50871105 Pharmaceuticals 118,509 $29,362,974.93 2.71%
Exelixis, Inc. EXEL 30161Q104 Biotechnology 415,247 $28,357,217.63 2.62%
Illumina, Inc. ILMN 452327109 Biotechnology 86,099 $18,081,650.99 1.67%
Medpace Holdings, Inc. MEDP 58506Q109 Biotechnology 25,684 $16,614,209.08 1.53%
Neurocrine Biosciences, Inc. NBIX 64125C109 Biotechnology 88,082 $14,345,034.52 1.33%
Elanco Animal Health Incorporated ELAN 28414H103 Pharmaceuticals 534,739 $14,277,531.30 1.32%
Halozyme Therapeutics, Inc. HALO 40637H109 Biotechnology 149,655 $14,336,949.00 1.32%
BioMarin Pharmaceutical Inc. BMRN 09061G101 Pharmaceuticals 218,308 $13,410,660.44 1.24%
Charles River Laboratories International, Inc. CRL 159864107 Biotechnology 36,060 $12,016,995.00 1.11%
Alnylam Pharmaceuticals, Inc. ALNY 02043Q107 Biotechnology 53,399 $7,977,810.60 0.74%
Moderna, Inc. MRNA 60770K107 Biotechnology 36,927 $7,266,864.33 0.67%
Amneal Pharmaceuticals, Inc. AMRX 03168L105 Pharmaceuticals 296,601 $6,489,629.88 0.60%
TG Therapeutics, Inc. TGTX 88322Q108 Biotechnology 95,424 $6,309,434.88 0.58%
Adaptive Biotechnologies Corporation ADPT 00650F109 Biotechnology 207,935 $5,917,830.10 0.55%
Roivant Sciences Ltd. ROIV G76279101 Biotechnology 149,590 $5,793,620.70 0.54%
Spyre Therapeutics, Inc. SYRE 00773J202 Biotechnology 58,010 $5,885,694.60 0.54%
Ligand Pharmaceuticals Inc. (Class B) LGND 53220K504 Biotechnology 18,242 $5,449,067.82 0.50%
Kymera Therapeutics, Inc. KYMR 501575104 Biotechnology 43,609 $5,282,358.17 0.49%
Oruka Therapeutics, Inc. ORKA 687604108 Biotechnology 55,948 $5,356,461.52 0.49%
Alkermes Plc ALKS G01767105 Pharmaceuticals 110,274 $5,166,336.90 0.48%
Tango Therapeutics, Inc. TNGX 87583X109 Biotechnology 226,868 $4,966,140.52 0.46%
10X Genomics, Inc. (Class A) TXG 88025U109 Biotechnology 82,972 $4,735,212.04 0.44%
Guardant Health, Inc. GH 40131M109 Biotechnology 32,582 $4,728,951.48 0.44%
Iovance Biotherapeutics, Inc. IOVA 462260100 Biotechnology 634,230 $4,744,040.40 0.44%
Krystal Biotech, Inc. KRYS 501147102 Biotechnology 14,415 $4,545,626.10 0.42%
Protagonist Therapeutics, Inc. PTGX 74366E102 Biotechnology 35,067 $4,459,119.72 0.41%
Liquidia Technologies, Inc. LQDA 53635D202 Biotechnology 76,012 $4,287,076.80 0.40%
Twist Bioscience Corporation TWST 90184D100 Biotechnology 37,279 $4,337,411.65 0.40%
Dianthus Therapeutics, Inc. DNTH 252828108 Biotechnology 49,060 $4,120,058.80 0.38%
Caris Life Sciences, Inc. CAI 142152107 Biotechnology 203,284 $3,964,038.00 0.37%
Enliven Therapeutics Inc. ELVN 29337E102 Biotechnology 89,507 $4,017,969.23 0.37%
Travere Therapeutics, Inc. TVTX 89422G107 Pharmaceuticals 78,183 $3,927,913.92 0.36%
ACADIA Pharmaceuticals Inc. ACAD 004225108 Biotechnology 179,237 $3,195,795.71 0.30%
Corcept Therapeutics Inc. CORT 218352102 Pharmaceuticals 45,712 $3,098,816.48 0.29%
Arrowhead Pharmaceuticals, Inc. ARWR 04280A100 Biotechnology 62,892 $2,711,274.12 0.25%
US Dollar $USD Other 2,460,242 $2,460,241.77 0.23%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  First Trust Funds Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2026 All rights reserved.